 | • レポートコード：QYR2104Z2776 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、止血診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（研究所用アナライザー、ポイントオブケア検査システム）、用途別市場規模（病院、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・止血診断の市場動向 ・企業の競争状況、市場シェア ・止血診断の種類別市場規模（研究所用アナライザー、ポイントオブケア検査システム） ・止血診断の用途別市場規模（病院、診断センター、その他） ・止血診断の北米市場規模2016-2027（アメリカ、カナダ） ・止血診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・止血診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・止血診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・止血診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Thermo Fisher Scientific、Roche、Nihon Kohden、Sysmex、Siemens Healthineers、Instrumentation Laboratory、Beckman Coulter、Grifols） ・結論 |
Hemophilia, vitamin k deficiency, and disseminated intravascular coagulation are some of the factors responsible for blood clotting disorders that not only requires relevant treatment, but also timely and affordable diagnosis.
Market Analysis and Insights: Global Hemostasis Diagnostics Market
The global Hemostasis Diagnostics market size is projected to reach US$ 762.2 million by 2026, from US$ 558.9 million in 2019, at a CAGR of 4.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemostasis Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemostasis Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemostasis Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemostasis Diagnostics market.
Global Hemostasis Diagnostics Scope and Market Size
Hemostasis Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemostasis Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Laboratory Analyzers
Point-of-Care Testing Systems
Segment by Application
Hospitals
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Thermo Fisher Scientific
Roche
Nihon Kohden
Sysmex
Siemens Healthineers
Instrumentation Laboratory
Beckman Coulter
Grifols
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemostasis Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laboratory Analyzers
1.2.3 Point-of-Care Testing Systems
1.3 Market by Application
1.3.1 Global Hemostasis Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hemostasis Diagnostics Market Perspective (2016-2027)
2.2 Hemostasis Diagnostics Growth Trends by Regions
2.2.1 Hemostasis Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemostasis Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Hemostasis Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Hemostasis Diagnostics Industry Dynamic
2.3.1 Hemostasis Diagnostics Market Trends
2.3.2 Hemostasis Diagnostics Market Drivers
2.3.3 Hemostasis Diagnostics Market Challenges
2.3.4 Hemostasis Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemostasis Diagnostics Players by Revenue
3.1.1 Global Top Hemostasis Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Hemostasis Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Hemostasis Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemostasis Diagnostics Revenue
3.4 Global Hemostasis Diagnostics Market Concentration Ratio
3.4.1 Global Hemostasis Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemostasis Diagnostics Revenue in 2020
3.5 Hemostasis Diagnostics Key Players Head office and Area Served
3.6 Key Players Hemostasis Diagnostics Product Solution and Service
3.7 Date of Enter into Hemostasis Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemostasis Diagnostics Breakdown Data by Type
4.1 Global Hemostasis Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Hemostasis Diagnostics Forecasted Market Size by Type (2022-2027)
5 Hemostasis Diagnostics Breakdown Data by Application
5.1 Global Hemostasis Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Hemostasis Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hemostasis Diagnostics Market Size (2016-2027)
6.2 North America Hemostasis Diagnostics Market Size by Type
6.2.1 North America Hemostasis Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Hemostasis Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Hemostasis Diagnostics Market Size by Type (2016-2027)
6.3 North America Hemostasis Diagnostics Market Size by Application
6.3.1 North America Hemostasis Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Hemostasis Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Hemostasis Diagnostics Market Size by Application (2016-2027)
6.4 North America Hemostasis Diagnostics Market Size by Country
6.4.1 North America Hemostasis Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Hemostasis Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hemostasis Diagnostics Market Size (2016-2027)
7.2 Europe Hemostasis Diagnostics Market Size by Type
7.2.1 Europe Hemostasis Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Hemostasis Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Hemostasis Diagnostics Market Size by Type (2016-2027)
7.3 Europe Hemostasis Diagnostics Market Size by Application
7.3.1 Europe Hemostasis Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Hemostasis Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Hemostasis Diagnostics Market Size by Application (2016-2027)
7.4 Europe Hemostasis Diagnostics Market Size by Country
7.4.1 Europe Hemostasis Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Hemostasis Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hemostasis Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Hemostasis Diagnostics Market Size by Type
8.2.1 Asia-Pacific Hemostasis Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemostasis Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemostasis Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemostasis Diagnostics Market Size by Application
8.3.1 Asia-Pacific Hemostasis Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemostasis Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemostasis Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemostasis Diagnostics Market Size by Region
8.4.1 Asia-Pacific Hemostasis Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemostasis Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hemostasis Diagnostics Market Size (2016-2027)
9.2 Latin America Hemostasis Diagnostics Market Size by Type
9.2.1 Latin America Hemostasis Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Hemostasis Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Hemostasis Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Hemostasis Diagnostics Market Size by Application
9.3.1 Latin America Hemostasis Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Hemostasis Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Hemostasis Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Hemostasis Diagnostics Market Size by Country
9.4.1 Latin America Hemostasis Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Hemostasis Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemostasis Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Hemostasis Diagnostics Market Size by Type
10.2.1 Middle East & Africa Hemostasis Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemostasis Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemostasis Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemostasis Diagnostics Market Size by Application
10.3.1 Middle East & Africa Hemostasis Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemostasis Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemostasis Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemostasis Diagnostics Market Size by Country
10.4.1 Middle East & Africa Hemostasis Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemostasis Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Hemostasis Diagnostics Introduction
11.1.4 Abbott Revenue in Hemostasis Diagnostics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Hemostasis Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Hemostasis Diagnostics Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Hemostasis Diagnostics Introduction
11.3.4 Roche Revenue in Hemostasis Diagnostics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Nihon Kohden
11.4.1 Nihon Kohden Company Details
11.4.2 Nihon Kohden Business Overview
11.4.3 Nihon Kohden Hemostasis Diagnostics Introduction
11.4.4 Nihon Kohden Revenue in Hemostasis Diagnostics Business (2016-2021)
11.4.5 Nihon Kohden Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Details
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Hemostasis Diagnostics Introduction
11.5.4 Sysmex Revenue in Hemostasis Diagnostics Business (2016-2021)
11.5.5 Sysmex Recent Development
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Details
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Hemostasis Diagnostics Introduction
11.6.4 Siemens Healthineers Revenue in Hemostasis Diagnostics Business (2016-2021)
11.6.5 Siemens Healthineers Recent Development
11.7 Instrumentation Laboratory
11.7.1 Instrumentation Laboratory Company Details
11.7.2 Instrumentation Laboratory Business Overview
11.7.3 Instrumentation Laboratory Hemostasis Diagnostics Introduction
11.7.4 Instrumentation Laboratory Revenue in Hemostasis Diagnostics Business (2016-2021)
11.7.5 Instrumentation Laboratory Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Hemostasis Diagnostics Introduction
11.8.4 Beckman Coulter Revenue in Hemostasis Diagnostics Business (2016-2021)
11.8.5 Beckman Coulter Recent Development
11.9 Grifols
11.9.1 Grifols Company Details
11.9.2 Grifols Business Overview
11.9.3 Grifols Hemostasis Diagnostics Introduction
11.9.4 Grifols Revenue in Hemostasis Diagnostics Business (2016-2021)
11.9.5 Grifols Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hemostasis Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laboratory Analyzers
Table 3. Key Players of Point-of-Care Testing Systems
Table 4. Global Hemostasis Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hemostasis Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hemostasis Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hemostasis Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Hemostasis Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hemostasis Diagnostics Market Share by Regions (2022-2027)
Table 10. Hemostasis Diagnostics Market Trends
Table 11. Hemostasis Diagnostics Market Drivers
Table 12. Hemostasis Diagnostics Market Challenges
Table 13. Hemostasis Diagnostics Market Restraints
Table 14. Global Hemostasis Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hemostasis Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Hemostasis Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostasis Diagnostics as of 2020)
Table 17. Ranking of Global Top Hemostasis Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hemostasis Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hemostasis Diagnostics Product Solution and Service
Table 21. Date of Enter into Hemostasis Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hemostasis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hemostasis Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Hemostasis Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hemostasis Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hemostasis Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hemostasis Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Hemostasis Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hemostasis Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hemostasis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hemostasis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hemostasis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hemostasis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hemostasis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hemostasis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hemostasis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hemostasis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hemostasis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hemostasis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hemostasis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hemostasis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hemostasis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hemostasis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemostasis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemostasis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemostasis Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hemostasis Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hemostasis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hemostasis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hemostasis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hemostasis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hemostasis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hemostasis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hemostasis Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hemostasis Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemostasis Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemostasis Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemostasis Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hemostasis Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Hemostasis Diagnostics Product
Table 64. Abbott Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Hemostasis Diagnostics Product
Table 69. Thermo Fisher Scientific Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Hemostasis Diagnostics Product
Table 74. Roche Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Nihon Kohden Company Details
Table 77. Nihon Kohden Business Overview
Table 78. Nihon Kohden Hemostasis Diagnostics Product
Table 79. Nihon Kohden Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Nihon Kohden Recent Development
Table 81. Sysmex Company Details
Table 82. Sysmex Business Overview
Table 83. Sysmex Hemostasis Diagnostics Product
Table 84. Sysmex Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Sysmex Recent Development
Table 86. Siemens Healthineers Company Details
Table 87. Siemens Healthineers Business Overview
Table 88. Siemens Healthineers Hemostasis Diagnostics Product
Table 89. Siemens Healthineers Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Siemens Healthineers Recent Development
Table 91. Instrumentation Laboratory Company Details
Table 92. Instrumentation Laboratory Business Overview
Table 93. Instrumentation Laboratory Hemostasis Diagnostics Product
Table 94. Instrumentation Laboratory Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Instrumentation Laboratory Recent Development
Table 96. Beckman Coulter Company Details
Table 97. Beckman Coulter Business Overview
Table 98. Beckman Coulter Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Beckman Coulter Recent Development
Table 100. Grifols Company Details
Table 101. Grifols Business Overview
Table 102. Grifols Hemostasis Diagnostics Product
Table 103. Grifols Revenue in Hemostasis Diagnostics Business (2016-2021) & (US$ Million)
Table 104. Grifols Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemostasis Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Laboratory Analyzers Features
Figure 3. Point-of-Care Testing Systems Features
Figure 4. Global Hemostasis Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Hemostasis Diagnostics Report Years Considered
Figure 9. Global Hemostasis Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hemostasis Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hemostasis Diagnostics Market Share by Regions: 2020 VS 2027
Figure 12. Global Hemostasis Diagnostics Market Share by Regions (2022-2027)
Figure 13. Global Hemostasis Diagnostics Market Share by Players in 2020
Figure 14. Global Top Hemostasis Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostasis Diagnostics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hemostasis Diagnostics Revenue in 2020
Figure 16. Global Hemostasis Diagnostics Revenue Market Share by Type (2016-2021)
Figure 17. Global Hemostasis Diagnostics Revenue Market Share by Type (2022-2027)
Figure 18. North America Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hemostasis Diagnostics Market Share by Type (2016-2027)
Figure 20. North America Hemostasis Diagnostics Market Share by Application (2016-2027)
Figure 21. North America Hemostasis Diagnostics Market Share by Country (2016-2027)
Figure 22. United States Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemostasis Diagnostics Market Share by Type (2016-2027)
Figure 26. Europe Hemostasis Diagnostics Market Share by Application (2016-2027)
Figure 27. Europe Hemostasis Diagnostics Market Share by Country (2016-2027)
Figure 28. Germany Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemostasis Diagnostics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hemostasis Diagnostics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hemostasis Diagnostics Market Share by Region (2016-2027)
Figure 38. China Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemostasis Diagnostics Market Share by Type (2016-2027)
Figure 46. Latin America Hemostasis Diagnostics Market Share by Application (2016-2027)
Figure 47. Latin America Hemostasis Diagnostics Market Share by Country (2016-2027)
Figure 48. Mexico Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemostasis Diagnostics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hemostasis Diagnostics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hemostasis Diagnostics Market Share by Country (2016-2027)
Figure 54. Turkey Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hemostasis Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 60. Nihon Kohden Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 61. Sysmex Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 62. Siemens Healthineers Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 63. Instrumentation Laboratory Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 64. Beckman Coulter Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 65. Grifols Revenue Growth Rate in Hemostasis Diagnostics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の止血用装置市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hemostasis Devices Market The global Hemostasis Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…- 世界のポイントオブケア（POC）診断用ポリメラーゼ連鎖反応（PCR）市場規模・現状・予測（2021年-2027年） Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics marke…
- 世界のポイントオブケア診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point-of-Care Diagnostics Market The global Point-of-Care Diagnostics market size is projected to reach US$ 33460 million by 2026, from US$ 22640 million in 2019, at a CAGR of 5.7% during 2021-2026. With industry-standard accuracy in analysis and high data integr…
- 世界の止血・組織シーリング剤市場規模・現状・予測（2021年-2027年） Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mech…
- 世界の止血・組織シーリング剤市場規模・現状・予測（2021年-2027年） Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mech…